Market Performance of Everquote and Peer Companies
Everquote (NASDAQ: EVER) experienced a modest decline of –2.68 % during the 24‑hour period ending at 11:35 AM Central Europe on Thursday, 22 October 2026. At the close of that session, one share of Everquote traded at approximately USD 22.11 on major exchanges.
The company’s market capitalisation stands at USD 782.1 million, with a circulating supply of 31.8 million shares. In the last 24 hours, trading volume reached about USD 8.6 million. Since the close of the previous month, Everquote’s shares have risen 13.09 %. The 200‑day simple moving average (SMA) is currently USD 20.53, indicating a sustained upward trajectory over that period. Everquote’s all‑time high (52‑week high) was USD 28.73 on 12 December 2025, while the 52‑week low was USD 13.88 on 1 May 2026.
Peer Performance in the Last 24 Hours
| Ticker | Last‑Day Change | Current Price (USD) | Market Capitalisation (USD mn) | P/E Ratio |
|---|---|---|---|---|
| OIG (Orion180 Insurance Group) | –4.66 % | 9.01 | 935.9 | 59.55 |
| PLOW (Douglas Dynamics) | +0.60 % | 40.4 | 926.8 | 18.16 |
| HAFC (Hanmi) | +0.10 % | 31.5 | 925.8 | 10.59 |
| NPKI (Npk) | +1.65 % | 11.09 | 926.4 | 23.73 |
| AVBP (Arrivent Biopharma) | +1.43 % | 19.12 | 936.1 | – |
Douglas Dynamics (PLOW)
Douglas Dynamics recorded a modest +0.60 % gain, closing at USD 40.40. The manufacturer of commercial work‑truck attachments and equipment, the company announced that its third‑quarter 2026 financial results will be released after the market close on Monday, 2 November 2026. A conference call to discuss the outcomes is scheduled for Tuesday, 3 November at 9:00 a.m. Central Time, featuring the company’s president, chief executive officer and chief financial officer. The call will be simulcast on the company’s website and accessible by phone. Douglas Dynamics highlighted its position as a leading North American manufacturer and up‑fitter of commercial work‑truck attachments, emphasizing continuous improvement and high‑quality products. Its portfolio is divided into Work Truck Attachments (including snow and ice control and crane products) and Work Truck Solutions (up‑fit and storage solutions). No further financial details were disclosed at this time.
Arrivent Biopharma (AVBP)
Arrivent Biopharma closed up +1.43 % at USD 19.12. Analyst revisions across several research firms—including B. Riley Financial, Citigroup, and Guggenheim—have lowered price targets from the mid‑$40s to the low‑$20s while maintaining a buy stance. The company’s most recent earnings report delivered a negative quarterly EPS, falling short of consensus estimates, and forecasts for the year remain negative. Despite these setbacks, institutional investors continue to adjust positions, with notable purchases by several funds. The company, focused on precision oncology for genetically defined lung cancers, continues to advance its lead EGFR inhibitor candidate. Analysts overall maintain a moderate buy view, reflecting a cautious but not overly pessimistic outlook amid ongoing product development and market dynamics.
Other Peer Movements
- Orion180 Insurance Group (OIG) declined –4.66 % to USD 9.01, with a market cap of USD 935.9 million and a high price‑to‑earnings ratio of 59.55.
- Hanmi (HAFC) saw a marginal increase of +0.10 % to USD 31.50, market capitalisation USD 925.8 million, and a P/E of 10.59.
- Npk (NPKI) experienced a rise of +1.65 % to USD 11.09, market cap USD 926.4 million, and a P/E of 23.73.
EverQuote: Company Overview
EverQuote, Inc. is an internet‑based marketing firm operating within the communication services sector. The company provides a digital platform that connects consumers with auto‑insurance carriers and agents to fulfil their auto‑insurance needs. EverQuote serves customers across the United States and is accessible through its website at www.everquote.com . The company went public on Nasdaq on 28 June 2018.
By continuing to refine its matching algorithm and expanding its agent network, EverQuote aims to enhance customer experience and drive growth in a highly competitive insurance‑tech landscape.
